We are proud to announce our latest collaboration with Somnera, Inc., the developers of the Somnera™ System – a breakthrough medical device to treat Obstructive Sleep Apnea (OSA).
The Somnera™ System ushers in a new era of sleep for patients who don’t want or cannot tolerate CPAP. Somnera provides the only alternative to CPAP that has been proven to be just as effective as CPAP in two randomized, controlled studies. The small, elegant, and easy to use design is complemented by new features designed to engage and delight Somnera’s customers.
Somnera is revolutionizing the sleep market,” says Preferred Depot CEO, Isaac Elkah. “We are thrilled to partner with Somnera to provide operational support for their innovative devices.”
Somnera is a privately-held sleep solutions and connected health innovator currently launching its new treatment for OSA in the US. Somnera secured FDA clearance in June 2020, holds 10 issued patents and has secured U.S. reimbursement authorization. Somnera’s technology is cloud-connected, taking advantage of the latest advances in cloud-based data analytics, patient engagement, and automated reorder/subscription models. Somnera’s dedicated management team is poised to capture market share and transform the treatment of Sleep Apnea.